ONE WORLD PHARMA, INC. (PNTTE) financial statements (2021 and earlier)

Company profile

Business Address 3471 WEST OQUENDO ROAD, SUITE 301
LAS VEGAS, NV 89118
State of Incorp. NV
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

9/30/2020
TTM
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
9/30/2015
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments 282   36
Cash and cash equivalents 282   36
Receivables 80     
Inventory, net of allowances, customer advances and progress billings 25     
Inventory 25     
Prepaid expense  1   1
Other current assets 267     
Other undisclosed current assets (80)     
Total current assets: 5741  36
Noncurrent Assets
Operating lease, right-of-use asset 503
Property, plant and equipment 698     
Other undisclosed noncurrent assets 73     
Total noncurrent assets: 1,273     
TOTAL ASSETS: 1,8471  36
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including: 440010118 
Accounts payable 3310    
Accrued liabilities 110     
Other undisclosed accounts payable and accrued liabilities   10118 
Debt 185     
Due to related parties  0883114 
Other undisclosed current liabilities 507     
Total current liabilities: 1,1330984123 
Noncurrent Liabilities
Long-term debt and lease obligation 453     
Operating lease, liability 453
Liabilities, other than long-term debt      3
Due to related parties      3
Total noncurrent liabilities: 453    3
Total liabilities: 1,58609841233
Stockholders' equity
Stockholders' equity attributable to parent, including: 2610(98)(41)(20)3
Common stock 4515555
Additional paid in capital 8,15015425252525
Accumulated other comprehensive loss (16)     
Accumulated deficit (8,167)(155)(128)(71)(49)(27)
Other undisclosed stockholders' equity attributable to parent 250     
Total stockholders' equity: 2610(98)(41)(20)3
TOTAL LIABILITIES AND EQUITY: 1,8471  36

Income statement (P&L) ($ in thousands)

9/30/2020
TTM
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
9/30/2015
Operating expenses (5,821)(27)(57)(37) (27)
Other operating expense, net
(Other Nonrecurring (Income) Expense)
      (4)
Other undisclosed operating income      4
Operating loss: (5,821)(27)(57)(37) (27)
Nonoperating income (expense) (387)  15  
Investment income, nonoperating    15  
Other nonoperating expense (387)     
Interest and debt expense (383)     
Loss before gain (loss) on sale of properties: (6,590)(27)(57)(22) (27)
Other undisclosed net income 383     
Net loss available to common stockholders, diluted: (6,207)(27)(57)(22) (27)

Comprehensive Income ($ in thousands)

9/30/2020
TTM
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
9/30/2015
Net loss: (6,207)(27)(57)(22) (27)
Comprehensive loss: (6,207)(27)(57)(22) (27)
Other undisclosed comprehensive loss, net of tax, attributable to parent (12)     
Comprehensive loss, net of tax, attributable to parent: (6,219)(27)(57)(22) (27)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: